glp-1 leptin Hypothalamic anorexigenic signaling pathways (leptin, amylin, and proopiomelanocortin) are semaglutide (GLP-1 analog) targets in obesity control in mice New obesity drug combo uses

The main advantage: no injection-site reactions

Systematic review and meta-analysis of the therapeutic management of patients with cervicogenic dizziness

Metformin primarily reduces liver glucose production and improves insulin sensitivity, while GLP-1 agonists directly activate appetite-suppressing hormones in the brain

This dual action helps maintain healthier glucose levelsa vital benefit for our patients with type 2 diabetes

Researchers collected data from 33,280 adults with type 2 diabetes living in Stockholm who started GLP-1 or DPP-IV therapy from 2008 to 2021 and had no record of using either class of drug in the year before initiation (mean age, 63.7 years